scispace - formally typeset
J

José Melo-Cristino

Researcher at Instituto de Medicina Molecular

Publications -  150
Citations -  5346

José Melo-Cristino is an academic researcher from Instituto de Medicina Molecular. The author has contributed to research in topics: Serotype & Multilocus sequence typing. The author has an hindex of 39, co-authored 139 publications receiving 4681 citations. Previous affiliations of José Melo-Cristino include University of Lisbon & Universidade Nova de Lisboa.

Papers
More filters
Journal ArticleDOI

Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.

TL;DR: The characterization of group A streptococci recovered during 2004-2006 revealed that resistance was not stable during this period and that the decline in erythromycin resistance observed during2004-2006 was due to a decrease in the prevalence of isolates presenting the M phenotype, while the proportion of isolate expressing the MLS(B) phenotype remained stable.
Journal ArticleDOI

Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci

TL;DR: Staphylococci can contribute to persistence and severity of diabetic foot infections, leading to treatment failure and to the possibility of transmitting these features to other microorganisms sharing the same niche, as well as present resistance to medically important antibiotics and harbour virulence determinants.
Journal ArticleDOI

Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012.

TL;DR: A seasonal rise in severity of IGASI suggested that generalised seasonal increase in host susceptibility, rather than introduction of more virulent strains may play a role in the pathogenesis of these potentially fatal infections.
Journal ArticleDOI

Epidemiological survey of the first case of vancomycin-resistant Staphylococcus aureus infection in Europe

TL;DR: Despite the absence of VRSA dissemination, the recent increase in the incidence of lineages belonging to CC5 in some European countries, including Portugal, may result in more frequent opportunities for the emergence ofVRSA.

Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of S

TL;DR: The results obtained in this work do not exclude the importance of mutations in resistance to fluoroquinolones in S. aureus, yet they underline the contribution of efflux systems for the emergence of high-level resistance.